Skip to main content

Milestone 9.P

ADRD Specific Milestone

LBD biomarker development.


Success Criteria

  • Evaluate existing LBD biomarker efforts, including systematic assessments of their impact on identifying pre-dementia LBD and prodromal or at-risk for LBD patients.
  • Informed by this evaluation, develop new biomarkers for LBD in both model systems and in humans, and in a diversity of tissues including in the periphery.
  • Validate at least one biomarker in multi-site large scale trials.
  • Incorporate at least one new LBD biomarker into studies designed to diagnose prodromal LBD.


Research Implementation Area
AD Related Dementias - Specific
Timeline
2016–2023
Status
In Progress

Accomplishments/Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations